BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18565744)

  • 1. Accuracy and reproducibility of conformal radiotherapy using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).
    Stanley S; Griffiths S; Sydes MR; Moore AR; Syndikus I; Dearnaley DP;
    Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):582-90. PubMed ID: 18565744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.
    Sydes MR; Stephens RJ; Moore AR; Aird EG; Bidmead AM; Fallowfield LJ; Graham J; Griffiths S; Mayles WP; McGuire A; Stanley S; Warrington AP; Dearnaley DP;
    Radiother Oncol; 2004 Aug; 72(2):199-211. PubMed ID: 15297138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A versatile phantom for quality assurance in the UK Medical Research Council (MRC) RT01 trial (ISRCTN47772397) in conformal radiotherapy for prostate cancer.
    Moore AR; Warrington AP; Aird EG; Bidmead AM; Dearnaley DP
    Radiother Oncol; 2006 Jul; 80(1):82-5. PubMed ID: 16828908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers.
    Wu J; Haycocks T; Alasti H; Ottewell G; Middlemiss N; Abdolell M; Warde P; Toi A; Catton C
    Radiother Oncol; 2001 Nov; 61(2):127-33. PubMed ID: 11690677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Set-up error in supine-positioned patients immobilized with two different modalities during conformal radiotherapy of prostate cancer.
    Fiorino C; Reni M; Bolognesi A; Bonini A; Cattaneo GM; Calandrino R
    Radiother Oncol; 1998 Nov; 49(2):133-41. PubMed ID: 10052878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of Beam cath in the verification process for prostate cancer radiotherapy.
    McNair HA; Parker C; Hansen VN; Askew L; Mukherjee R; Nutting C; Norman AR; Dearnaley DP
    Clin Oncol (R Coll Radiol); 2004 Apr; 16(2):138-47. PubMed ID: 15074738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397).
    Mayles WP; Moore AR; Aird EG; Bidmead AM; Dearnaley DP; Griffiths SE; Warrington AP;
    Radiother Oncol; 2004 Nov; 73(2):199-207. PubMed ID: 15622611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality Assurance.
    Mason MD; Moore R; Jones G; Lewis G; Donovan JL; Neal DE; Hamdy FC; Lane JA; Staffurth JN;
    Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e92-e100. PubMed ID: 27425582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electronic portal imaging vs kilovoltage imaging in fiducial marker image-guided radiotherapy for prostate cancer: an analysis of set-up uncertainties.
    Gill S; Thomas J; Fox C; Kron T; Thompson A; Chander S; Williams S; Tai KH; Duchesne G; Foroudi F
    Br J Radiol; 2012 Feb; 85(1010):176-82. PubMed ID: 21976627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of supine vs. prone positioning in patients undergoing escalated dose conformal radiotherapy for prostate cancer.
    Bayley AJ; Catton CN; Haycocks T; Kelly V; Alasti H; Bristow R; Catton P; Crook J; Gospodarowicz MK; McLean M; Milosevic M; Warde P
    Radiother Oncol; 2004 Jan; 70(1):37-44. PubMed ID: 15036850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.
    Martinez AA; Pataki I; Edmundson G; Sebastian E; Brabbins D; Gustafson G
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):61-9. PubMed ID: 11163498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397).
    Syndikus I; Morgan RC; Sydes MR; Graham JD; Dearnaley DP;
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):773-83. PubMed ID: 19836155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dynamic compensation strategy to correct patient-positioning errors in conformal prostate radiotherapy.
    Lauve AD; Siebers JV; Crimaldi AJ; Hagan MP; Kealla PJ
    Med Phys; 2006 Jun; 33(6):1879-87. PubMed ID: 16872095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer.
    Martinez AA; Yan D; Lockman D; Brabbins D; Kota K; Sharpe M; Jaffray DA; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1226-34. PubMed ID: 11483333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of daily online set-up errors and organ displacement uncertainty during conformal radiation treatment of the prostate.
    Osei EK; Jiang R; Barnett R; Fleming K; Panjwani D
    Br J Radiol; 2009 Jan; 82(973):49-61. PubMed ID: 18955413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial.
    Dearnaley DP; Khoo VS; Norman AR; Meyer L; Nahum A; Tait D; Yarnold J; Horwich A
    Lancet; 1999 Jan; 353(9149):267-72. PubMed ID: 9929018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class solutions for conformal external beam prostate radiotherapy.
    Khoo VS; Bedford JL; Webb S; Dearnaley DP
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):1109-20. PubMed ID: 12605991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transabdominal ultrasonography, computed tomography and electronic portal imaging for 3-dimensional conformal radiotherapy for prostate cancer.
    Jereczek-Fossa BA; Cattani F; Garibaldi C; Zerini D; Cambria R; Boboc GI; Valenti M; Kowalczyk A; Vavassori A; Ivaldi GB; Ciocca M; Matei DV; De Cobelli O; Orecchia R
    Strahlenther Onkol; 2007 Nov; 183(11):610-6. PubMed ID: 17960336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Conformal radiation therapy with or without intensity modulation in the treatment of localized prostate cancer].
    Maingon P; Bolla M; Truc G; Bosset M; Peignaux K; Ammor A
    Cancer Radiother; 2005 Nov; 9(6-7):382-7. PubMed ID: 16095944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.